DNA Sequencing Market by End-user, Solution and Geography - Forecast and Analysis 2023-2027

Published: Aug 2023 Pages: 168 SKU: IRTNTR40874

DNA Sequencing Market Analysis Report 2023-2027:

The global DNA sequencing market size is estimated to grow by USD 10,690.39 million at a CAGR of 15.52% between 2022 and 2027. 

Cost serves as a major factor in any market. Due to numerous advances in technology, the global DNA sequencing market has seen a significant drop in cost over the past few years. The NHGRI has gathered a lot of information on DNA sequencing costs for many years through the sequencing centers funded by the Institute. The NHGRI has been able to analyze and summarise the information obtained, which enables an assessment of advances in DNA genotyping technology. In the past, the cost structure for DNA sequencing involved a lot of ambiguity, which left it unclear whether the cost included any of the steps to sequence or just a sequencing run. Thus, as a solution to this problem, a new all-inclusive approach was developed. This approach gives better insights into the cost structure of a prioritizing project and aids end-users and funding agencies in improving their research plans. 

Technavio has segmented the market into  End-user, Solution, and Geography

  • The end-user is classified into academic research, clinical research, hospitals & clinics, and pharmaceutical & biotechnology comp.
  • The solution is classified into products and services
  • The geography segment includes key regions such as North America, Europe, Asia, and the Rest of the World (ROW)

It also includes an in-depth analysis of drivers, trends, and challenges. Our report examines historic data from 2017 to 2021, besides analyzing the current market scenario.

What will be the size of the DNA Sequencing Market During the Forecast Period?

To learn more about this report, Request Free Sample

DNA Sequencing Market Segmentation by End-user, Solution, and Geography Analysis

End-user Analysis

Academic Research

The market share growth by the academic research segment will be significant during the forecast period. Academic research held the largest market share in the global DNA sequencing market in 2022. The evolution of the academic research segment is being driven by factors including high interest in innovative work in DNA sequencing and the government.

Get a glance at the market contribution of various segments View a PDF Sample

The academic research segment was valued at USD 2,892.01 million in 2017. High-quality data generated from genome sequencing projects helps researchers to find novel targets for drug development and a better understanding of human disease pathogenesis. The increased demand for higher-resolution DNA sequences is expected to propel the university research sector, which, in turn, will fuel the growth of the global DNA sequencing market during the forecast period.

Solution Analysis

Products

The products segment held the largest market share in 2022 in terms of market segmentation by solutions due to the increasing demand for consumables in academic organizations and research centers and their expanding use in a wide range of genetic testing procedures. Based on products, the market can be divided into consumables and instruments. In 2022, the consumables segment held the largest market share among products. For studies on epigenetics and chronic disease, DNA sequencing consumables are used for various purposes, including sample preparation as well as the production of sequence libraries. The introduction of user-friendly tools, such as portable DNA sequencers, and the fast-growing volume of genomics-based R&D enterprises, are driving the sales of these instruments. Due to these factors, the products segment is expected to retain its leading position in the global DNA sequencing market during the forecast period.

Services

The services segment is expected to demonstrate the fastest growth during the forecast period. This can be attributed to the development of various bioinformatics tools and software, as well as the increasing dependence on outsourcing.  Outsourcing services will be more cost-effective because companies no longer have to make substantial investments in establishing sequencing facilities and are then expected to absorb the subsequent maintenance and operational costs. Thus, these factors are also prompting more vendors to offer DNA sequencing services. Another reason for the segment's rapid growth is the increasing liking among most research centers and academic organizations to outsource NGS-related projects to CROs. The use of NGS technology generally requires large capital investments and a large lab footprint. Hence, large labs with specific DNA prioritizing needs or small and medium-sized laboratories generally choose to outsource their DNA sequencing to a dedicated sequencing service facility.

Regional Analysis

For more insights about the market share of various regions View PDF Sample now!

North America is estimated to contribute 37% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that will shape the market during the forecast period. North America accounted for the largest market share in 2022 and is expected to retain its market-leading position throughout the forecast period. This can be attributed to the rising incidence of chronic diseases, increasing healthcare expenditure, and the existence of several key vendors in the region. Several leading biotechnology and life sciences companies have their headquarters in the US and Canada.

Moreover, the demand for DNA sequencing to develop medicines in North America is also driven by the large number of studies carried out. DNA sequencing reagents have widespread applications in clinical trials for the identification of potential drug target spots in the genome as well as in the evaluation of the safety and efficacy of novel treatments. Thus, the large number of clinical trials conducted in the US will further increase the demand for DNA sequencing in the region.

COVID Recovery Analysis

The COVID-19 outbreak affected the region in three main ways, namely by creating supply chain and market disruptions for DNA sequencing consumables and instruments; by directly influencing the production of and demand for DNA sequencing products; and through its financial impact on DNA sequencing market players, which, in turn, adversely impacted the regional market growth in 2020. However, since 2021, the widespread vaccination campaign and the ease of lockdowns were responsible for normalcy in the region, which was a positive influence on the market's focus. The rising cases of chronic diseases such as cancer in the region are expected to fuel the growth of the DNA sequencing market in the region during the forecast period.

Buy Now Full Report and Discover More

Key DNA Sequencing Market Players 

Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market. The report also includes detailed analyses of the competitive landscape of the market and information about 20 market companies, including:

10X Genomics Inc. - The company offers DNA sequencing such as Linked Reads genomics it provides contextual information about the genome from short reads.

  • Abbott Laboratories
  • Agilent Technologies Inc.
  • Azenta Inc.
  • Becton Dickinson and Co.
  • BGI Genomics Co. Ltd.
  • Bio Rad Laboratories Inc.
  • Danaher Corp.
  • Eurofins Scientific SE
  • F. Hoffmann La Roche Ltd.
  • Illumina Inc.
  • Laboratory Corp. of America Holdings
  • Macrogen Inc.
  • Merck KGaA
  • Pacific Biosciences of California Inc.
  • PerkinElmer Inc.
  • QIAGEN NV
  • SeqLL Inc.
  • Tecan Trading AG
  • Thermo Fisher Scientific Inc.

Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.

DNA Sequencing Market: Key Drivers, Trends, Challenges, and Customer Landscape

There are multiple factors influencing market growth. Our researchers analyzed the data with 2022 as the base year, along with the key drivers, trends, and challenges. 

Key DNA Sequencing Market Drivers

The growing adoption of NGS is driving growth in the DNA sequencing market. Next-Generation Sequencing has made it possible to sequence the entire human genome in a day and is revolutionizing genomic research by massively parallel DNA sequencing. NGS is increasingly used in the diagnosis and treatment of several prevalent chronic diseases, such as cancer and infectious diseases. 

However, NGS technology can detect sequence variations effectively and provide several genetic markers, including common and rare variants, which further spurs its adoption. The ability to conduct DNA sequencing simultaneously, which makes it easier and more precise in treating diseases because of earlier diagnosis and detection, constitutes one factor that is driving the increased adoption of NGS. The wide use of NGS in DNA sequencing and its growing adoption among end-users are expected to drive the growth of the global DNA sequencing market during the forecast period.

Significant DNA Sequencing Market Trends

The automation of DNA Sequencing is a key trend in the DNA sequencing market. It is a repetitive, complex, and long process to determine the full nucleotide sequence of large DNA molecules, making it an excellent area for automation. Automated sequencing has been developed to sequence large quantities of DNA using the principle of the Sanger chain-termination method. The automation of DNA sequencing machines has led to the rapid development of computer software for analyzing, assembling, and manipulating DNA sequences.

Moreover, automated DNA sequencing equipment eliminates the use of radioactive isotopes for labeling DNA by employing a fluorescent dye to label the nucleotides instead. These fluorescent dyes do not pose a risk to the environment and do not require special handling or disposal. Because of these factors, the automation of DNA sequencing is gaining prominence and is expected to have a positive impact on the growth of the global DNA sequencing market during the forecast period.

Major DNA Sequencing Market Challenges

The inadequate resources for DNA sequencing in developing countries is a major challenge faced by the DNA sequencing market.  Advanced technologies in DNA technology have made it possible to increase the accuracy of investigative investigations and reduce overall sequencing costs significantly, thereby increasing its use and increasing applications. However, DNA sequencing remains largely underutilized in developing countries, leading to limited R&D funding. This can be attributed to factors such as a lack of skillful personnel, the high costs associated with establishing and continuing a sequencing facility, the low quality of outsourcing services, and the limited access to tools for genomic data analysis and manipulation.

However, the lack of human development and education capacity in emerging countries creates a barrier to market growth by failing to provide adequate training. Furthermore, genomic data analysis and manipulation have become crucial tools for genomic research. Moreover, outsourcing businesses in many evolving countries provide low-quality services, with the risk of the entire outsourcing procedure failing at any stage, which, in turn, leads to losses in terms of both time and cost. Hence, the availability of limited resources for DNA sequencing in developing countries will be a major challenge for the growth of the market in focus during the forecast period.

Buy Now Full Report and Discover More

Key DNA Sequencing Market Customer Landscape

The market report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.

Global DNA Sequencing Market Customer Landscape

Segment Overview

The DNA sequencing market report forecasts market growth by revenue at global, regional & country levels and provides an analysis of the latest trends and growth opportunities from 2017 to 2027. 

  • End-user Outlook (USD Million, 2017 - 2027)
    • Academic research
    • Clinical research
    • Hospitals & clinics
    • Pharmaceutical & biotechnology comp.
  • Solution Outlook (USD Million, 2017 - 2027)
    • Products
    • Services
  • Region Outlook (USD Million, 2017 - 2027)
    • North America
      • The U.S.
      • Canada
    • Europe
      • The U.K.
      • Germany
      • France
      • Rest of Europe
    • Asia
      • China
      • India
    • Rest of the world
      • Argentina
      • Australia
      • Brazil

DNA Sequencing Market Scope

Report Coverage

Details

Page number

168

Base year

2022

Historic period

2017-2021

Forecast period

2023-2027

Growth momentum & CAGR

Accelerate at a CAGR of 15.52%

Market growth 2023-2027

USD 10,690.39 million

Market structure

Fragmented

YoY growth 2022-2023(%)

15.16

Regional analysis

North America, Europe, Asia, and the Rest of the World (ROW)

Performing market contribution

North America at 37%

Key countries

US, UK, Germany, China, and Japan

Competitive landscape

Leading Vendors, Market Positioning of Vendors, Competitive Strategies, and Industry Risks

Key companies profiled

10X Genomics Inc., Abbott Laboratories, Agilent Technologies Inc., Azenta Inc., Becton Dickinson and Co., BGI Genomics Co. Ltd., Bio Rad Laboratories Inc., Danaher Corp., Eurofins Scientific SE, F. Hoffmann La Roche Ltd., Illumina Inc., Laboratory Corp. of America Holdings, Macrogen Inc., Merck KGaA, Pacific Biosciences of California Inc., PerkinElmer Inc., QIAGEN NV, SeqLL Inc., Tecan Trading AG, and Thermo Fisher Scientific Inc.

Market dynamics

Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and Market condition analysis for the forecast period.

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

View Sample PDF at your Fingertips

What are the Key Data Covered in this DNA Sequencing Market Research Report?

  • CAGR of the market during the forecast period
  • Detailed information on factors that will drive the growth of the DNA Sequencing Market between 2023 and 2027
  • Precise estimation of the size of the DNA sequencing market size and its contribution to the market in focus on the parent market
  • Detailed analysis of customer landscape covering Diver of price sensitivity, Adoption of the lifecycle, and key purchase criteria 
  • Companies landscape comparing criticality of inputs and factors of differentiation
  • Exclusive Matrix on companies' position and classification
  • Accurate predictions about upcoming trends and changes in consumer behavior
  • Growth of the market industry across North America, Europe, Asia, and the Rest of the World (ROW)
  • A thorough analysis of the market’s competitive landscape and detailed information about companies
  • Comprehensive analysis of factors that will challenge the growth of DNA sequencing market companies

We can help! Our analysts can customize this market research report to meet your requirements. Get in touch

1 Executive Summary

  • 1.1 Market overview
    • Exhibit 01: Executive Summary – Chart on Market Overview
    • Exhibit 02: Executive Summary – Data Table on Market Overview
    • Exhibit 03: Executive Summary – Chart on Global Market Characteristics
    • Exhibit 04: Executive Summary – Chart on Market by Geography
    • Exhibit 05: Executive Summary – Chart on Market Segmentation by End-user
    • Exhibit 06: Executive Summary – Chart on Market Segmentation by Solution
    • Exhibit 07: Executive Summary – Chart on Incremental Growth
    • Exhibit 08: Executive Summary – Data Table on Incremental Growth
    • Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
    • Exhibit 10: Parent market
    • Exhibit 11: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
    • Exhibit 12: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
    • Exhibit 13: Market segments
  • 3.3 Market size 2022
    • 3.4 Market outlook: Forecast for 2022-2027
      • Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
      • Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
      • Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
      • Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

    4 Historic Market Size

    • 4.1 Global DNA sequencing market 2017 - 2021
      • Exhibit 18: Historic Market Size – Data Table on global dna sequencing market 2017 - 2021 ($ million)
    • 4.2 End-user Segment Analysis 2017 - 2021
      • Exhibit 19: Historic Market Size – End-user Segment 2017 - 2021 ($ million)
    • 4.3 Solution Segment Analysis 2017 - 2021
      • Exhibit 20: Historic Market Size – Solution Segment 2017 - 2021 ($ million)
    • 4.4 Geography Segment Analysis 2017 - 2021
      • Exhibit 21: Historic Market Size – Geography Segment 2017 - 2021 ($ million)
    • 4.5 Country Segment Analysis 2017 - 2021
      • Exhibit 22: Historic Market Size – Country Segment 2017 - 2021 ($ million)

    5 Five Forces Analysis

    • 5.1 Five forces summary
      • Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
    • 5.2 Bargaining power of buyers
      • Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
    • 5.3 Bargaining power of suppliers
      • Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
    • 5.4 Threat of new entrants
      • Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027
    • 5.5 Threat of substitutes
      • Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027
    • 5.6 Threat of rivalry
      • Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027
    • 5.7 Market condition
      • Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

    6 Market Segmentation by End-user

    • 6.1 Market segments
      • Exhibit 30: Chart on End-user - Market share 2022-2027 (%)
      • Exhibit 31: Data Table on End-user - Market share 2022-2027 (%)
    • 6.2 Comparison by End-user
      • Exhibit 32: Chart on Comparison by End-user
      • Exhibit 33: Data Table on Comparison by End-user
    • 6.3 Academic research - Market size and forecast 2022-2027
      • Exhibit 34: Chart on Academic research - Market size and forecast 2022-2027 ($ million)
      • Exhibit 35: Data Table on Academic research - Market size and forecast 2022-2027 ($ million)
      • Exhibit 36: Chart on Academic research - Year-over-year growth 2022-2027 (%)
      • Exhibit 37: Data Table on Academic research - Year-over-year growth 2022-2027 (%)
    • 6.4 Clinical research - Market size and forecast 2022-2027
      • Exhibit 38: Chart on Clinical research - Market size and forecast 2022-2027 ($ million)
      • Exhibit 39: Data Table on Clinical research - Market size and forecast 2022-2027 ($ million)
      • Exhibit 40: Chart on Clinical research - Year-over-year growth 2022-2027 (%)
      • Exhibit 41: Data Table on Clinical research - Year-over-year growth 2022-2027 (%)
    • 6.5 Hospitals and clinics - Market size and forecast 2022-2027
      • Exhibit 42: Chart on Hospitals and clinics - Market size and forecast 2022-2027 ($ million)
      • Exhibit 43: Data Table on Hospitals and clinics - Market size and forecast 2022-2027 ($ million)
      • Exhibit 44: Chart on Hospitals and clinics - Year-over-year growth 2022-2027 (%)
      • Exhibit 45: Data Table on Hospitals and clinics - Year-over-year growth 2022-2027 (%)
    • 6.6 Pharmaceutical and biotechnology companies - Market size and forecast 2022-2027
      • Exhibit 46: Chart on Pharmaceutical and biotechnology companies - Market size and forecast 2022-2027 ($ million)
      • Exhibit 47: Data Table on Pharmaceutical and biotechnology companies - Market size and forecast 2022-2027 ($ million)
      • Exhibit 48: Chart on Pharmaceutical and biotechnology companies - Year-over-year growth 2022-2027 (%)
      • Exhibit 49: Data Table on Pharmaceutical and biotechnology companies - Year-over-year growth 2022-2027 (%)
    • 6.7 Market opportunity by End-user
      • Exhibit 50: Market opportunity by End-user ($ million)
      • Exhibit 51: Data Table on Market opportunity by End-user ($ million)

    7 Market Segmentation by Solution

    • 7.1 Market segments
      • Exhibit 52: Chart on Solution - Market share 2022-2027 (%)
      • Exhibit 53: Data Table on Solution - Market share 2022-2027 (%)
    • 7.2 Comparison by Solution
      • Exhibit 54: Chart on Comparison by Solution
      • Exhibit 55: Data Table on Comparison by Solution
    • 7.3 Products - Market size and forecast 2022-2027
      • Exhibit 56: Chart on Products - Market size and forecast 2022-2027 ($ million)
      • Exhibit 57: Data Table on Products - Market size and forecast 2022-2027 ($ million)
      • Exhibit 58: Chart on Products - Year-over-year growth 2022-2027 (%)
      • Exhibit 59: Data Table on Products - Year-over-year growth 2022-2027 (%)
    • 7.4 Services - Market size and forecast 2022-2027
      • Exhibit 60: Chart on Services - Market size and forecast 2022-2027 ($ million)
      • Exhibit 61: Data Table on Services - Market size and forecast 2022-2027 ($ million)
      • Exhibit 62: Chart on Services - Year-over-year growth 2022-2027 (%)
      • Exhibit 63: Data Table on Services - Year-over-year growth 2022-2027 (%)
    • 7.5 Market opportunity by Solution
      • Exhibit 64: Market opportunity by Solution ($ million)
      • Exhibit 65: Data Table on Market opportunity by Solution ($ million)

    8 Customer Landscape

    • 8.1 Customer landscape overview
      • Exhibit 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

    9 Geographic Landscape

    • 9.1 Geographic segmentation
      • Exhibit 67: Chart on Market share by geography 2022-2027 (%)
      • Exhibit 68: Data Table on Market share by geography 2022-2027 (%)
    • 9.2 Geographic comparison
      • Exhibit 69: Chart on Geographic comparison
      • Exhibit 70: Data Table on Geographic comparison
    • 9.3 North America - Market size and forecast 2022-2027
      • Exhibit 71: Chart on North America - Market size and forecast 2022-2027 ($ million)
      • Exhibit 72: Data Table on North America - Market size and forecast 2022-2027 ($ million)
      • Exhibit 73: Chart on North America - Year-over-year growth 2022-2027 (%)
      • Exhibit 74: Data Table on North America - Year-over-year growth 2022-2027 (%)
    • 9.4 Europe - Market size and forecast 2022-2027
      • Exhibit 75: Chart on Europe - Market size and forecast 2022-2027 ($ million)
      • Exhibit 76: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
      • Exhibit 77: Chart on Europe - Year-over-year growth 2022-2027 (%)
      • Exhibit 78: Data Table on Europe - Year-over-year growth 2022-2027 (%)
    • 9.5 Asia - Market size and forecast 2022-2027
      • Exhibit 79: Chart on Asia - Market size and forecast 2022-2027 ($ million)
      • Exhibit 80: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
      • Exhibit 81: Chart on Asia - Year-over-year growth 2022-2027 (%)
      • Exhibit 82: Data Table on Asia - Year-over-year growth 2022-2027 (%)
    • 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
      • Exhibit 83: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
      • Exhibit 84: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
      • Exhibit 85: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
      • Exhibit 86: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
    • 9.7 US - Market size and forecast 2022-2027
      • Exhibit 87: Chart on US - Market size and forecast 2022-2027 ($ million)
      • Exhibit 88: Data Table on US - Market size and forecast 2022-2027 ($ million)
      • Exhibit 89: Chart on US - Year-over-year growth 2022-2027 (%)
      • Exhibit 90: Data Table on US - Year-over-year growth 2022-2027 (%)
    • 9.8 UK - Market size and forecast 2022-2027
      • Exhibit 91: Chart on UK - Market size and forecast 2022-2027 ($ million)
      • Exhibit 92: Data Table on UK - Market size and forecast 2022-2027 ($ million)
      • Exhibit 93: Chart on UK - Year-over-year growth 2022-2027 (%)
      • Exhibit 94: Data Table on UK - Year-over-year growth 2022-2027 (%)
    • 9.9 Germany - Market size and forecast 2022-2027
      • Exhibit 95: Chart on Germany - Market size and forecast 2022-2027 ($ million)
      • Exhibit 96: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
      • Exhibit 97: Chart on Germany - Year-over-year growth 2022-2027 (%)
      • Exhibit 98: Data Table on Germany - Year-over-year growth 2022-2027 (%)
    • 9.10 China - Market size and forecast 2022-2027
      • Exhibit 99: Chart on China - Market size and forecast 2022-2027 ($ million)
      • Exhibit 100: Data Table on China - Market size and forecast 2022-2027 ($ million)
      • Exhibit 101: Chart on China - Year-over-year growth 2022-2027 (%)
      • Exhibit 102: Data Table on China - Year-over-year growth 2022-2027 (%)
    • 9.11 Japan - Market size and forecast 2022-2027
      • Exhibit 103: Chart on Japan - Market size and forecast 2022-2027 ($ million)
      • Exhibit 104: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
      • Exhibit 105: Chart on Japan - Year-over-year growth 2022-2027 (%)
      • Exhibit 106: Data Table on Japan - Year-over-year growth 2022-2027 (%)
    • 9.12 Market opportunity by geography
      • Exhibit 107: Market opportunity by geography ($ million)
      • Exhibit 108: Data Tables on Market opportunity by geography ($ million)

    10 Drivers, Challenges, and Trends

    • 10.1 Market drivers
      • 10.2 Market challenges
        • 10.3 Impact of drivers and challenges
          • Exhibit 109: Impact of drivers and challenges in 2022 and 2027
        • 10.4 Market trends

          11 Vendor Landscape

          • 11.1 Overview
            • 11.2 Vendor landscape
              • Exhibit 110: Overview on Criticality of inputs and Factors of differentiation
            • 11.3 Landscape disruption
              • Exhibit 111: Overview on factors of disruption
            • 11.4 Industry risks
              • Exhibit 112: Impact of key risks on business

            12 Vendor Analysis

            • 12.1 Vendors covered
              • Exhibit 113: Vendors covered
            • 12.2 Market positioning of vendors
              • Exhibit 114: Matrix on vendor position and classification
            • 12.3 10X Genomics Inc.
              • Exhibit 115: 10X Genomics Inc. - Overview
              • Exhibit 116: 10X Genomics Inc. - Product / Service
              • Exhibit 117: 10X Genomics Inc. - Key offerings
            • 12.4 Abbott Laboratories
              • Exhibit 118: Abbott Laboratories - Overview
              • Exhibit 119: Abbott Laboratories - Business segments
              • Exhibit 120: Abbott Laboratories - Key news
              • Exhibit 121: Abbott Laboratories - Key offerings
              • Exhibit 122: Abbott Laboratories - Segment focus
            • 12.5 Agilent Technologies Inc.
              • Exhibit 123: Agilent Technologies Inc. - Overview
              • Exhibit 124: Agilent Technologies Inc. - Business segments
              • Exhibit 125: Agilent Technologies Inc. - Key offerings
              • Exhibit 126: Agilent Technologies Inc. - Segment focus
            • 12.6 Azenta Inc.
              • Exhibit 127: Azenta Inc. - Overview
              • Exhibit 128: Azenta Inc. - Business segments
              • Exhibit 129: Azenta Inc. - Key offerings
              • Exhibit 130: Azenta Inc. - Segment focus
            • 12.7 Becton Dickinson and Co.
              • Exhibit 131: Becton Dickinson and Co. - Overview
              • Exhibit 132: Becton Dickinson and Co. - Business segments
              • Exhibit 133: Becton Dickinson and Co. - Key news
              • Exhibit 134: Becton Dickinson and Co. - Key offerings
              • Exhibit 135: Becton Dickinson and Co. - Segment focus
            • 12.8 BGI Genomics Co. Ltd.
              • Exhibit 136: BGI Genomics Co. Ltd. - Overview
              • Exhibit 137: BGI Genomics Co. Ltd. - Product / Service
              • Exhibit 138: BGI Genomics Co. Ltd. - Key offerings
            • 12.9 Bio Rad Laboratories Inc.
              • Exhibit 139: Bio Rad Laboratories Inc. - Overview
              • Exhibit 140: Bio Rad Laboratories Inc. - Business segments
              • Exhibit 141: Bio Rad Laboratories Inc. - Key news
              • Exhibit 142: Bio Rad Laboratories Inc. - Key offerings
              • Exhibit 143: Bio Rad Laboratories Inc. - Segment focus
            • 12.10 Danaher Corp.
              • Exhibit 144: Danaher Corp. - Overview
              • Exhibit 145: Danaher Corp. - Business segments
              • Exhibit 146: Danaher Corp. - Key news
              • Exhibit 147: Danaher Corp. - Key offerings
              • Exhibit 148: Danaher Corp. - Segment focus
            • 12.11 Eurofins Scientific SE
              • Exhibit 149: Eurofins Scientific SE - Overview
              • Exhibit 150: Eurofins Scientific SE - Business segments
              • Exhibit 151: Eurofins Scientific SE - Key news
              • Exhibit 152: Eurofins Scientific SE - Key offerings
              • Exhibit 153: Eurofins Scientific SE - Segment focus
            • 12.12 F. Hoffmann La Roche Ltd.
              • Exhibit 154: F. Hoffmann La Roche Ltd. - Overview
              • Exhibit 155: F. Hoffmann La Roche Ltd. - Business segments
              • Exhibit 156: F. Hoffmann La Roche Ltd. - Key news
              • Exhibit 157: F. Hoffmann La Roche Ltd. - Key offerings
              • Exhibit 158: F. Hoffmann La Roche Ltd. - Segment focus
            • 12.13 Illumina Inc.
              • Exhibit 159: Illumina Inc. - Overview
              • Exhibit 160: Illumina Inc. - Business segments
              • Exhibit 161: Illumina Inc. - Key news
              • Exhibit 162: Illumina Inc. - Key offerings
              • Exhibit 163: Illumina Inc. - Segment focus
            • 12.14 Macrogen Inc.
              • Exhibit 164: Macrogen Inc. - Overview
              • Exhibit 165: Macrogen Inc. - Product / Service
              • Exhibit 166: Macrogen Inc. - Key offerings
            • 12.15 PerkinElmer Inc.
              • Exhibit 167: PerkinElmer Inc. - Overview
              • Exhibit 168: PerkinElmer Inc. - Business segments
              • Exhibit 169: PerkinElmer Inc. - Key news
              • Exhibit 170: PerkinElmer Inc. - Key offerings
              • Exhibit 171: PerkinElmer Inc. - Segment focus
            • 12.16 QIAGEN NV
              • Exhibit 172: QIAGEN NV - Overview
              • Exhibit 173: QIAGEN NV - Product / Service
              • Exhibit 174: QIAGEN NV - Key news
              • Exhibit 175: QIAGEN NV - Key offerings
            • 12.17 Thermo Fisher Scientific Inc.
              • Exhibit 176: Thermo Fisher Scientific Inc. - Overview
              • Exhibit 177: Thermo Fisher Scientific Inc. - Business segments
              • Exhibit 178: Thermo Fisher Scientific Inc. - Key news
              • Exhibit 179: Thermo Fisher Scientific Inc. - Key offerings
              • Exhibit 180: Thermo Fisher Scientific Inc. - Segment focus

            13 Appendix

            • 13.1 Scope of the report
              • 13.2 Inclusions and exclusions checklist
                • Exhibit 181: Inclusions checklist
                • Exhibit 182: Exclusions checklist
              • 13.3 Currency conversion rates for US$
                • Exhibit 183: Currency conversion rates for US$
              • 13.4 Research methodology
                • Exhibit 184: Research methodology
                • Exhibit 185: Validation techniques employed for market sizing
                • Exhibit 186: Information sources
              • 13.5 List of abbreviations
                • Exhibit 187: List of abbreviations

              Research Framework

              Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

              INFORMATION SOURCES

              Primary sources

              • Manufacturers and suppliers
              • Channel partners
              • Industry experts
              • Strategic decision makers

              Secondary sources

              • Industry journals and periodicals
              • Government data
              • Financial reports of key industry players
              • Historical data
              • Press releases

              DATA ANALYSIS

              Data Synthesis

              • Collation of data
              • Estimation of key figures
              • Analysis of derived insights

              Data Validation

              • Triangulation with data models
              • Reference against proprietary databases
              • Corroboration with industry experts

              REPORT WRITING

              Qualitative

              • Market drivers
              • Market challenges
              • Market trends
              • Five forces analysis

              Quantitative

              • Market size and forecast
              • Market segmentation
              • Geographical insights
              • Competitive landscape

              PURCHASE FULL REPORT OF

              dna sequencing market

              Key Questions Answered

              • What are the key global market and the regional market share?
              • What are the revenue-generating key market segments?
              • What are the key factors driving and challenging this market’s growth?
              • Who are the key market vendors and their growth strategies?
              • What are the latest trends influencing the growth of this market?
              • What are the variables influencing the market growth in the primary regions?
              • What are the factors influencing the growth of the parent market?

              Why should you prefer Technavio's market insights report?

              • Off-the-shelf research reports
              • Reports can be tailored to meet the customer's needs
              • Trusted by more than 100 fortune 500 organizations
              • Information about the market's key drivers, trends, and challenges
              • Parent market analysis
              • Every week, 50,000 people visit our subscription platform
              • Detailed vendors report with competitive landscape
              • Covid-19 impact and recovery analysis
              • Data on revenue-generating market segments
              • Details on the market shares of various regions
              • Five-force market analysis